Kinin-Induced Prolongation of Action-Potential Duration in Right Ventricular Muscle from Rat: Involvement of B1 and B2 Receptors
Authors:
- R. CardinalRCR. Cardinal
- A. AdamAAA. Adam
- G. DrapeauGDG. Drapeau
- R. NadeauRNR. Nadeau
- 1 August 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 28 (2) , 337-343
Abstract
Summary Previous work has shown that, in rat ventricular muscle, bradykinin (BK) causes a dose-dependent increase in action potential duration (APD), an action that may be responsible for APD prolongation by captopril (kininase II). To determine which kinin receptor might be involved in APD prolongation, we studied the effects of B1- and B2-receptor agonists, as well as those of antagonists and mergepta (a kininase I inhibitor) added during BK superfusion. Action potentials were recorded by using the standard glass microelectrode technique in rat ventricular muscle preparations. Action-potential characteristics were compared between preparations superfused with peptide/drug-free Tyrode's solution (control group) and preparations superfused with peptide/drug-containing solution. APD was significantly longer in preparations superfused with BK (10-8M) than in the control group. The APD prolongation induced by BK, a known B2-receptor agonist, was significantly reduced by Hoe 140 (a B2 antagonist) and also by Lys[Leu8]des-Arg9-BK (a B1 antagonist), an action presumably related to inhibition of B1 receptor stimulation by the BK metabolite des-Arg9-BK. When mergepta was added in the presence of BK, APD prolongation by BK was significantly reduced, an effect that could have been related to reduced B1-receptor stimulation after inhibition of the endogenous generation of des-Arg9-BK by kininase I. Sar4-[d-Phe8]des-Arg9-BK, a B1-receptor agonist that is not degraded by kininase II, also prolonged APD. We conclude that both B1 and B2 receptors may be involved in APD prolongation induced in rat ventricular muscle preparations.Keywords
This publication has 36 references indexed in Scilit:
- Prolongation by captopril of action potential duration in the normal and hypertrophied rat ventricle: direct action or inhibition of the local angiotensin converting enzyme?Cardiovascular Research, 1994
- Protective effects of bradykinin on the ischaemic heart: implication of the B1 receptorBritish Journal of Pharmacology, 1993
- Bradykinin receptors: Pharmacological properties and biological rolesPharmacology & Therapeutics, 1992
- Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia‐induced arrhythmias in anaesthetized dogsBritish Journal of Pharmacology, 1991
- In Vivo Effect of Bradykinin During Ischemia and ReperfusionJournal of Cardiovascular Pharmacology, 1991
- Studies on the induction of pharmacological responses to des‐Arg9‐bradykinin in vitro and in vivoBritish Journal of Pharmacology, 1987
- The ability of des-Arg9-bradykinin to relax rabbit isolated mesenteric arteries is acquired during in vitro incubationEuropean Journal of Pharmacology, 1987
- Influence of Local Converting Enzyme Inhibition on Angiotensin and Bradykinin Effects in Ischemic Rat HeartsJournal of Cardiovascular Pharmacology, 1987
- Relaxation of isolated mesenteric arteries by des-Arg9-bradykinin stimulation of B1 receptorsEuropean Journal of Pharmacology, 1986
- De novo formation of vascular receptors for bradykininCanadian Journal of Physiology and Pharmacology, 1978